- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.
Metropolis Healthcare reported FY26 revenue of INR 1,646 Cr, with Q1 showing 17% growth. Management aims for 27-28% EBITDA margins (from 24.4%) driven by increased volumes and asset utilization. Strategic levers include expanding its 5,000+ center network, growing its TruHealth wellness packages (now 20% of business), and increasing high-margin specialty...
Metropolis Healthcare posted solid FY26 results with revenue hitting ₹1,646 Cr (+23.6%), EBITDA ₹401 Cr (+23%), and PAT ₹191 Cr (+19%). This volume-led growth continued into Q1 FY27, with revenue up 17% YoY to ₹450 Cr and EBITDA margin at 25.2% (+210 bps YoY). B2C and rural segments were standout...
Metropolis Healthcare's wholly-owned subsidiary, MQSPL, will issue Optionally Convertible Redeemable Preference Shares worth INR 0.01 Cr to Dr. Puneet Kumar Nigam. This move will result in MQSPL no longer being entirely owned by Metropolis but will remain a subsidiary.